-
Opthea IPO: What Investors Should Know About The Genentech, Regeneron Challenger
Thursday, October 15, 2020 - 4:15pm | 696Read More...Opthea, an Australian clinical stage biotech company, is going public to help fund its Phase 3 trials and take on two large biotech companies. About Opthea: The main area of focus for Opthea Ltd (NASDAQ: OPT) is wet age-related macular degeneration, commonly referred to as AMD, and other...
-
The Man Behind Jet.Com; The Wall Street Journal Profiles Marc Lore
Monday, August 8, 2016 - 2:52pm | 523Read More...Marc Lore is the brains behind Jet.com, the retail e-commerce that Wal-Mart Stores, Inc. (NYSE: WMT) acquired on Monday for $3.3 billion. The Wall Street Journal profiled Lore on Monday following the acquisition announcement and quickly pointed out his plans to battle Amazon.com, Inc. (NASDAQ:...
-
Teva Pharmaceutical Subpoenaed By SEC in Bribery Charge
Monday, August 6, 2012 - 9:13am | 538Read More...As part of broad probe into potential violations of the 1977 Foreign Corrupt Practices Act, Israel-based Teva Pharmaceutical (NASDAQ: TEVA) has received a subpoena from the Securities and Exchange Commission. The SEC is seeking documentation for possible bribery charges against the largest generic...
